Matthanja Bieze, Oliver Poole, Arshia Delfani, Jane Heggie, Marcus Salvatori
{"title":"Characteristics and risk profile of the over fifty adult congenital heart surgical population, a retrospective cohort.","authors":"Matthanja Bieze, Oliver Poole, Arshia Delfani, Jane Heggie, Marcus Salvatori","doi":"10.3389/fcvm.2025.1568920","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The surgical and medical management of aging patients with adult congenital heart disease (ACHD) continues to innovate to meet the evolving needs of this unique patient population, leading to improved life expectancy and quality of life. However, the ACHD population is characterized by high morbidity and mortality. With this study, we aim to describe patient characteristics and surgical outcomes for the over fifty ACHD cardiac surgical cohort, focusing on risk factors for mortality and major complications.</p><p><strong>Methods: </strong>This was a retrospective cohort study including ACHD patients undergoing surgical repair from January 2004 to March 2023. Primary outcome was the composite of severe postoperative complications and secondary outcomes were 1-year mortality, ICU stay and hospital length of stay. Descriptive statistics, univariable and multivariable logistic regression models were used.</p><p><strong>Results: </strong>In the study period, 1381 patients with ACHD underwent cardiac surgery, of which 292 (20.5%) were over 50 years. In the overall group, the most common primary surgery was pulmonary valve replacement in 411 (29.8%), in the over 50 group this was ASD and VSD repairs in 102 (34.9%). The composite of major postoperative complications was different between the overall group and the over 50 years group (10.7% vs. 13.7%; <i>P</i> = 0.049), which in the over 50 group was associated with CPB time (180 min vs. 104 min, OR 1.01; 95%CI 1.00-1.03), and preoperative creatinine levels (84 vs. 77, OR 1.01; 95%CI 1.00-1.03). No difference was seen in 1-year mortality (<i>P</i> = 0.415).</p><p><strong>Conclusion: </strong>With careful patient selection and preoperative optimization, surgical risks remain low, even in aging ACHD patients. Although overall mortality rates are low, postoperative complications increase, and patients over 50 with DM, renal failure, long pump runs or postoperative stroke are at highest risk.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"12 ","pages":"1568920"},"PeriodicalIF":2.8000,"publicationDate":"2025-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12198246/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Cardiovascular Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fcvm.2025.1568920","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: The surgical and medical management of aging patients with adult congenital heart disease (ACHD) continues to innovate to meet the evolving needs of this unique patient population, leading to improved life expectancy and quality of life. However, the ACHD population is characterized by high morbidity and mortality. With this study, we aim to describe patient characteristics and surgical outcomes for the over fifty ACHD cardiac surgical cohort, focusing on risk factors for mortality and major complications.
Methods: This was a retrospective cohort study including ACHD patients undergoing surgical repair from January 2004 to March 2023. Primary outcome was the composite of severe postoperative complications and secondary outcomes were 1-year mortality, ICU stay and hospital length of stay. Descriptive statistics, univariable and multivariable logistic regression models were used.
Results: In the study period, 1381 patients with ACHD underwent cardiac surgery, of which 292 (20.5%) were over 50 years. In the overall group, the most common primary surgery was pulmonary valve replacement in 411 (29.8%), in the over 50 group this was ASD and VSD repairs in 102 (34.9%). The composite of major postoperative complications was different between the overall group and the over 50 years group (10.7% vs. 13.7%; P = 0.049), which in the over 50 group was associated with CPB time (180 min vs. 104 min, OR 1.01; 95%CI 1.00-1.03), and preoperative creatinine levels (84 vs. 77, OR 1.01; 95%CI 1.00-1.03). No difference was seen in 1-year mortality (P = 0.415).
Conclusion: With careful patient selection and preoperative optimization, surgical risks remain low, even in aging ACHD patients. Although overall mortality rates are low, postoperative complications increase, and patients over 50 with DM, renal failure, long pump runs or postoperative stroke are at highest risk.
老年成人先天性心脏病(ACHD)患者的外科和医疗管理不断创新,以满足这一独特患者群体不断变化的需求,从而提高预期寿命和生活质量。然而,ACHD人群的特点是高发病率和死亡率。在这项研究中,我们的目的是描述超过50例ACHD心脏手术队列的患者特征和手术结果,重点是死亡率和主要并发症的危险因素。方法:这是一项回顾性队列研究,包括2004年1月至2023年3月接受手术修复的ACHD患者。主要结局是严重术后并发症的综合,次要结局是1年死亡率、ICU住院时间和住院时间。采用描述性统计、单变量和多变量logistic回归模型。结果:研究期间,1381例ACHD患者接受了心脏手术,其中年龄在50岁以上的292例(20.5%)。在整个组中,最常见的主要手术是肺瓣膜置换术,411例(29.8%),在50岁以上的组中,ASD和VSD修复102例(34.9%)。总体组和50岁以上组术后主要并发症的综合发生率不同(10.7% vs 13.7%;P = 0.049), 50岁以上组与CPB时间相关(180 min vs. 104 min, OR 1.01;95%CI 1.00-1.03),术前肌酐水平(84比77,OR 1.01;95%可信区间1.00 - -1.03)。1年死亡率无差异(P = 0.415)。结论:通过谨慎的患者选择和术前优化,即使是老年ACHD患者,手术风险仍然很低。虽然总体死亡率较低,但术后并发症增加,50岁以上的糖尿病患者、肾衰竭、长时间泵运转或术后中风的风险最高。
期刊介绍:
Frontiers? Which frontiers? Where exactly are the frontiers of cardiovascular medicine? And who should be defining these frontiers?
At Frontiers in Cardiovascular Medicine we believe it is worth being curious to foresee and explore beyond the current frontiers. In other words, we would like, through the articles published by our community journal Frontiers in Cardiovascular Medicine, to anticipate the future of cardiovascular medicine, and thus better prevent cardiovascular disorders and improve therapeutic options and outcomes of our patients.